Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second malignancies following cancer therapy.

M C Fraser, M A Tucker

    Seminars in Oncology Nursing
    |February 1, 1989
    PubMed
    Summary

    Cancer treatments can cause new cancers, but their benefits outweigh these risks for life-threatening diseases. Ongoing research investigates these long-term effects of cancer therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.

    Genetics in medicine : official journal of the American College of Medical Genetics·2021
    Same author

    TET2 binds the androgen receptor and loss is associated with prostate cancer.

    Oncogene·2016
    Same author

    A 20 Year Clinical and Laboratory Study of Familial B-Chronic Lymphocytic Leukemia in a Single Kindred.

    Leukemia & lymphoma·2016
    Same author

    Revisiting the cost of carnivory in mammals.

    Journal of evolutionary biology·2016
    Same author

    Reliability of 24-h void frequency as an index of hydration status when euhydrated and hypohydrated.

    European journal of clinical nutrition·2016
    Same author

    Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.

    Leukemia·2015

    Area of Science:

    • Oncology
    • Cancer Research
    • Medical Ethics

    Background:

    • Cancer is a leading cause of death, especially in advanced stages.
    • Effective cancer treatments, while life-saving, can pose long-term health risks.
    • Balancing treatment benefits against potential carcinogenic effects is crucial.

    Purpose of the Study:

    • To investigate the risk of secondary malignancies following cancer treatment.
    • To understand the long-term effects of various cancer therapy regimens.
    • To inform clinical decision-making by weighing treatment benefits against risks.

    Main Methods:

    • Long-term follow-up studies of cancer patients.
    • Analysis of treatment regimens and their associated late effects.
    • Epidemiological investigation of treatment-related malignancies.

    Main Results:

    • Effective cancer therapies can increase the risk of developing new, secondary cancers.
    • The risk of these treatment-related malignancies is a significant concern in oncology.
    • Further research with extended follow-up is needed to fully understand these risks.

    Conclusions:

    • The benefits of life-saving cancer therapy must be carefully weighed against the risk of secondary cancers.
    • Continued investigation into the long-term effects of cancer treatments is essential.
    • Advancements in understanding late effects will improve patient care and risk management.

    Related Experiment Videos